Plant Health Care PLC
08 June 2006
Immediate release 8 June 2006
Plant Health Care plc
('PHC' or 'the Company')
Press speculation regarding Pre Tect
The Board has noted the recent press speculation regarding discussions with a
major US supermarket chain and the supply of its Pre Tect product.
As previously announced, following Pre-Tect's successful launch in the UK, the
Company's stated intention has been to commercialise its Pre-Tect product in the
US during 2006.
PHC can confirm it is in discussions with a number of interested parties in the
US regarding the supply of its Pre-Tect product. These discussions are ongoing
and at this stage there can be no guarantees that these discussions will be
successful.
Further announcements will be made as appropriate.
-ends-
For further information:
Plant Health Care plc Tavistock Communications
John Brady, Chief Executive Jeremy Carey
Christian Taylor-Wilkinson
+1 603 525 3702 Tel: 020 7920 3150
email: ctaylor-wilkinson@tavistock.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.